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Abstract
Background: A new influenza A (H1N1) virus was first found in April 2009 and proceeded to cause a global pandemic. We
compare the epidemiology and clinical presentation of seasonal influenza A (H1N1 and H3N2) and 2009 pandemic influenza
A (H1N1) (pH1N1) using a prospective surveillance system for acute respiratory disease in Guatemala.
Methodology/Findings: Patients admitted to two public hospitals in Guatemala in 2008–2009 who met a pneumonia case
definition, and ambulatory patients with influenza-like illness (ILI) at 10 ambulatory clinics were invited to participate. Data
were collected through patient interview, chart abstraction and standardized physical and radiological exams.
Nasopharyngeal swabs were taken from all enrolled patients for laboratory diagnosis of influenza A virus infection with
real-time reverse transcription polymerase chain reaction. We identified 1,744 eligible, hospitalized pneumonia patients,
enrolled 1,666 (96%) and tested samples from 1,601 (96%); 138 (9%) had influenza A virus infection. Surveillance for ILI
found 899 eligible patients, enrolled 801 (89%) and tested samples from 793 (99%); influenza A virus infection was identified
in 246 (31%). The age distribution of hospitalized pneumonia patients was similar between seasonal H1N1 and pH1N1
(P=0.21); the proportion of pneumonia patients ,1 year old with seasonal H1N1 (39%) and pH1N1 (37%) were similar
(P=0.42). The clinical presentation of pH1N1 and seasonal influenza A was similar for both hospitalized pneumonia and ILI
patients. Although signs of severity (admission to an intensive care unit, mechanical ventilation and death) were higher
among cases of pH1N1 than seasonal H1N1, none of the differences was statistically significant.
Conclusions/Significance: Small sample sizes may limit the power of this study to find significant differences between
seasonal influenza A and pH1N1. In Guatemala, influenza, whether seasonal or pH1N1, appears to cause severe disease
mainly in infants; targeted vaccination of children should be considered.
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Introduction
In April 2009, a new influenza A (H1N1) virus with a unique
combination of gene segments not previously identified among
influenza viruses was reported from the United States and Mexico
[1]. Immediately after the discovery of 2009 pandemic influenza A
(H1N1) (pH1N1), there were many reports comparing pH1N1
with previous influenza seasons as a way to predict the clinical
presentation of cases, the severity of the pandemic and high-risk
groups [1–3]. Studies eventually identified a number of important
differences between seasonal influenza and pH1N1, including a
younger age distribution [4], novel risk factors such as obesity
[5–7], and symptoms previously not frequently associated with
influenza infection, such as diarrhea and vomiting [8–10]. Other
reports found similarities between pH1N1 and seasonal influenza
with regard to basic reproduction number [11], range of severity
[8], clinical symptoms of hospitalized patients [2], and risk factors
for severe disease [12].
Comparisons of the epidemiology and clinical presentation of
seasonal influenza and pH1N1 can be complicated by the use of
case series from different years, as this might introduce biases due
to changes in practices or procedures as a result of the pandemic.
There have been few reports of concurrent comparisons of the
epidemiology of seasonal influenza and pH1N1 [13–18], and only
one from a low-resource setting in the tropics where, until recently,
influenza was not recognized as a significant problem [19–21].
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15826The 2009 influenza pandemic has helped to raise the profile of
influenza as an important cause of morbidity and mortality in
tropical developing countries but there is insufficient data from
resource-limited countries in the tropics.
In Guatemala, we have been conducting prospective, popula-
tion-based surveillance for severe acute respiratory disease and
influenza-like illness (ILI) since 2007. We recently reported on the
epidemiologic and clinical presentation of pH1N1 and described a
younger population than that affected by this virus in other parts
of the world [22]. In this paper, we present a comparison of the
clinical presentation of pH1N1, seasonal influenza A (H1N1) and
seasonal influenza A (H3N2) in a resource-limited country in the
tropics.
Methods
Human subjects
All patients 18 years of age or older were asked for verbal
consent for screening and, if they met the case definition, written,
informed consent to participate in the surveillance study. Relatives
of adult patients who were unconscious or unable to provide
consent on enrollment were asked to provide written, informed
consent for their relative to participate, and this consent was
renewed directly with the patient on regaining consciousness.
Parents or guardians of children ,18 years old were asked for
verbal consent to screen their child to determine eligibility, after
which written, informed consent was requested from the parents
or guardians and written, informed assent from children aged 7 to
17 years old. The protocol received approval from the institutional
review boards of the Universidad del Valle de Guatemala (UVG;
Guatemala City, Guatemala) and Centers for Disease Control and
Prevention (CDC; Atlanta, GA) and approval from the Guate-
malan Ministry of Public Health and Social Welfare (MSPAS;
Guatemala City, Guatemala). All positive pH1N1 results were
reported immediately to the MSPAS, who informed the local
public health authorities and patients in each site. The policy of
the MSPAS was to provide oseltamivir treatment free of charge to
all patients confirmed with pH1N1, although few patients received
timely antiviral treatment due to limited stocks and delays in
reporting results.
Study area and design
Guatemala, with a population over 14 million, has a gross
national income per capita of $2680 and is considered a middle-
income country by the World Bank (http://data.worldbank.org/
indicator/NY.GNP.PCAP.CD, accessed on 1 September 2010).
Seasonal influenza vaccination is part of the national immuniza-
tion schedule for persons $50 years old and healthcare workers,
but coverage among these groups is low despite the vaccine being
provided free of charge when available.
A description of the surveillance system for hospitalized
pneumonia and ambulatory ILI in Guatemala has been presented
previously [22]. Briefly, we conducted prospective surveillance for
hospitalized pneumonia and ILI in the Departments of Santa Rosa
(total population: 319,963) and Quetzaltenango (total population:
705,301). In Santa Rosa, surveillance for hospitalized pneumonia
began in November 2007 and was conducted at the only hospital
in the department, the National Hospital of Cuilapa. This hospital
is a 176-bed regional referral hospital with a four-bed pediatric
intensive care unit (ICU) and a four-bed adult ICU. In
Quetzaltenango, surveillance for hospitalized pneumonia began
in February 2009 and was conducted at the Western Regional
Hospital, one of two general-purpose public hospitals in the
department. The Western Regional Hospital is a larger facility
with 425 beds, including 22 pediatric and six adult ICU beds. Both
hospitals provide free care and serve mostly low- and mid-income
populations.
Surveillance for ILI in public ambulatory clinics began in Santa
Rosa in November 2007 in one health center (staffed by at least
one physician) and was then expanded to five additional health
posts (staffed by nurses) in June 2009 in response to the pH1N1
pandemic. Surveillance for ILI in ambulatory clinics in Quetzal-
tenango began in July 2009 in three health centers and one health
post. Health care is also provided free of charge at these
ambulatory clinics.
Prior to the pandemic, surveillance was limited to residents of
the catchment area of each facility, but this geographic restriction
was lifted in May 2009 to assist with monitoring the pandemic.
Case definitions
A case of pneumonia was defined as a patient admitted to the
hospital with at least one sign of acute infection and at least one
respiratory sign or symptom from the respective columns in
Table 1. A case of ILI was defined according to PAHO/CDC
guidelines as a patient presenting to an ambulatory health clinic
with a measured temperature .38uC and either cough or sore
throat [23]. Suspect cases were identified prospectively by study
nurses through review of ward registers or patient chief complaints
to find any patients with respiratory-related illnesses. In addition,
because this surveillance system also collects information on
gastrointestinal, neurological and febrile illnesses, patients admit-
ted for, or presenting with, complaints related to these syndromes
were also screened to determine whether they met the case
definition for pneumonia (hospital) or ILI (ambulatory clinic).
Table 1. Pneumonia Case Definition*, Guatemala, 2008-2009.
Signs of acute infection Symptoms of respiratory disease
Fever ($38uC) Tachypnea
Hypothermia (,35.5uC) ,2 months: $60 respiration rate (RR)
Abnormal white blood cell
count (WBC)
2 to 11 months: $50 RR
,5 years: ,5500 or .15000 12 to 59 months: $40 RR
$5 years: ,3000 or .11000 5 years and older: $20 RR
Abnormal white blood cell
differential
Cough
Sputum production
Pleuritic chest pain
Hemoptysis
Difficulty breathing
Shortness of breath
Sore throat
For children ,2 years old only
Child pauses repeatedly while
breastfeeding or drinking
Chest indrawing
Nasal flaring
Noisy breathing
*Pneumonia case definition: at least one sign of acute infection and at least one
symptom of respiratory disease.
doi:10.1371/journal.pone.0015826.t001
Seasonal and Pandemic Influenza in Guatemala
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15826Data and sample collection
In the hospital, clinical and epidemiologic data were collected
from both patient interviews and chart reviews. The highest
temperature (axillary) documented in the first 24 hours after
admission was recorded. A standard review of chest radiographs
was undertaken by a study radiologist, and a standard pulmonary
physical exam was performed by a study physician. Oxygen
saturation was measured by study nurses with a pulse oximeter.
Patients were asked whether they had been diagnosed with any of
the following chronic conditions: asthma, other lung disease,
diabetes, cancer, chronic cardiovascular disease (hypertension or
heart disease), liver disease, kidney disease or any immunocom-
promised condition (including HIV/AIDS).
In the ambulatory clinics, axillary temperature was measured by
study nurses and all other clinical and epidemiologic data were
collected through patient interview. In both the hospital and
ambulatory clinics, care sought for the current illness episode prior
to hospital admission or presentation to the ambulatory clinic was
reported by the patient or caregiver, along with any medicines
taken prior to admission or presentation. Diarrhea was defined as
three or more liquid or loose stools in a 24-hour period during the
last seven days. Trained study nurses took nasopharyngeal swabs
(NP) from all eligible and consenting patients with pneumonia and
ILI, whereas oropharyngeal (OP) swabs were also taken from
pneumonia patients; NP and OP swabs were put into one tube
with viral transport media and stored at 4uC until they could be
processed and sent to the laboratory at the UVG.
All patients with hospitalized pneumonia were asked to return
three to six weeks after discharge for a follow-up visit. Patients who
did not return by six weeks were followed with a phone call to
determine their vital status.
Laboratory diagnostics
A laboratory-confirmed case of influenza A was defined as a
case of pneumonia or ILI with influenza A virus infection as
determined by real-time reverse transcription polymerase-chain
reaction (rRT-PCR). Subtyping for influenza A to differentiate
viruses as seasonal H1N1 and H3N2 and pH1N1 was conducted
using a standardized CDC protocol [24]. We tested for adenovirus
[25] and other respiratory viruses (human metapneumovirus,
human parainfluenza viruses 1 to 3, influenza B and respiratory
syncytial virus [RSV]) using CDC rRT-PCR protocols (D.
Erdman, pers. comm.). A rapid antigen test (BinaxNow
TM,
Inverness Medical Professional Diagnostics, Princeton, NJ) to
detect infection with Streptococcus pneumoniae was used in urine
samples from all persons .10 years of age.
Data management and analysis
Data were collected using preprogrammed, hand-held personal
digital assistants. Only data from 2008 and 2009 were included in
this report. SAS v. 9.1 (Cary, NC) was used for analysis. The case
fatality proportion (CFP) was calculated as the number of deaths
among the cases of influenza A that occurred during hospitaliza-
tion or within six weeks of discharge divided by the total number
of cases of influenza A among hospitalized pneumonia patients.
For non-normally distributed continuous variables, the Mann-
Whitney U-test was used when two influenza subtypes were
compared, and the Kruskal-Wallis analysis of ranks was used when
three influenza subtypes were compared. Pearson’s chi-square
statistic or Fisher’s exact test were used to test for differences in
categorical variables between patients infected with different
influenza A virus subtypes and a P value of ,0.05 was considered
statistically significant. Variables with missing data for .10% of
the patients were analyzed to ensure no difference in terms of age,
sex or influenza A subtype between those with and without data.
Results
Between January 1, 2008 and December 31, 2009, we identified
1744 eligible hospitalized pneumonia patients and enrolled 1666
(96%) in the surveillance system; respiratory samples were
obtained and tested from 1602 (96%) of those enrolled. During
the same period, we identified 899 eligible ILI patients, enrolled
801 (89%), and obtained and tested samples from 793 (99%) of
those enrolled. There were no significant differences in either sex
or age distributions between the eligible pneumonia or ILI patients
who consented to enrollment and those who did not, or between
those enrolled pneumonia or ILI patients who agreed to have a
respiratory specimen taken and those who declined (data not
shown).
There were 138 (9%) hospitalized pneumonia and 246 (31%)
ILI patients with laboratory-confirmed influenza A virus infection
(Figure 1). The pH1N1 virus was the most common influenza A
virus subtype identified among both the pneumonia (76/138,
55%) and ILI (162/246, 66%) patients. Mixed pH1N1 and H3N2
virus infection occurred in one (0.4%) case of ILI. Of the 17 (12%)
samples positive for influenza A virus from pneumonia patients
and 11 (4%) from ILI patients that we were unable to subtype, all
but three occurred during the pandemic period. Among the
influenza A viruses that could be subtyped, there was no significant
difference in the subtype distribution between pneumonia and ILI
patients (P=0.17).
As a result of the small number of H3N2 in the hospitalized
pneumonia patients, we have limited comparison of the charac-
teristics of hospitalized pneumonia patients to those with seasonal
H1N1 and pH1N1.
During 2008, surveillance for hospitalized pneumonia and ILI
was underway only in Santa Rosa; all cases of seasonal influenza A
during 2008 occurred between January and August, with the peak
number of cases, both of hospitalized pneumonia (Figure 2a) and
ILI (Figure 2b), presenting between May and July. Thirty-three
(72%) of the cases of influenza A in 2008 were of the seasonal
H1N1 subtype. In 2009, cases of influenza were reported
beginning in February. There was an early peak of seasonal
H1N1 and H3N2 from March to May; however, the second peak
due to the pH1N1 virus, from June through September, was
greater. In 2009, 238 (70%) of the cases of influenza A were of the
pH1N1 subtype. There were 83 (57%) cases of seasonal influenza
A that occurred prior to the pandemic.
Concomitant with the 2009 influenza pandemic was a
significant increase in the number of RSV-associated respiratory
infections, which peaked in July and August (Figure 3).
Age distributions
The median age of hospitalized pneumonia patients with
influenza A was 3 years, and was lower for seasonal H1N1 (2
years) than for pH1N1 (4 years), but the difference was not
statistically significant (P=0.48) (Table 2). The proportions of
hospitalized pneumonia patients aged ,1 year old with seasonal
H1N1 (15/38; 39%) and pH1N1 (28/76; 37%) were similar
(P=0.42) (Figure 4a). Young adults 15 to 29 years old made up a
larger proportion of hospitalized pneumonia patients with pH1N1
(10/76; 13%) than seasonal H1N1 (1/38; 3%) but the difference
was not statistically significant (P=0.1). The proportion of
hospitalized pneumonia patients 60 years or older with seasonal
H1N1 (3/38; 8%) and pH1N1 (5/76; 7%) were similar (P=1.0).
Overall, there was no significant difference in the age distribution
Seasonal and Pandemic Influenza in Guatemala
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doi:10.1371/journal.pone.0015826.g001
Figure 2. Number of Patients with Influenza A by Month and Subtype, Guatemala, 2008-2009. Panel A: Hospitalized pneumonia patients.
Panel B: Influenza-like illness patients.
doi:10.1371/journal.pone.0015826.g002
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pH1N1 (P=0.21).
The age distribution of the ILI patients with influenza A differed
from that of hospitalized pneumonia patients (Figure 4b)
(P,0.001), with the median age of ILI patients (8 years) greater
than that for hospitalized pneumonia patients (3 years). Among
ILI patients, there was no statistical difference between the age
distribution of pH1N1 and seasonal H1N1 (P=0.22) or pH1N1
and H3N2 (P=0.25) (Table 3). The proportion of ILI patients
with pH1N1 that was ,1 year old (20/162, 12%) was not
significantly different from the proportion of ILI patients with
either seasonal H1N1 (10/51, 20%; P=0.25) or H3N2 (5/21,
24%; P=0.17). Similarly, the proportion of ILI patients with
pH1N1 that were $60 years old (3/162, 2%) was not significantly
different from seasonal H1N1 (0/51, 0%; P=1.0) or H3N2 (0/21,
0%; P=1.0). The group most affected by ILI due to influenza A
was school-age children from five to 14 years old with 108 (44%)
cases of influenza A; there was no statistically significant difference
in the proportion of pH1N1 cases aged 5 to 14 years old (80/162,
49%) in comparison to seasonal H1N1 (17/51, 33%; P=0.05) or
H3N2 (6/21; 29%; P=0.10).
Differences in clinical presentation of influenza A cases
by age
Children ,5 years old admitted with pneumonia and found to
have influenza A were more likely to have sought care previously
(42/67, 63%) than persons $5 years old (29/61, 48%), but the
difference was not statistically significant (P=0.09). There was no
difference in the proportion of children ,5 years old and persons
$5 years old with respect to having taken any medication,
including antipyretics and antivirals, within the 72 hours prior to
admission (data not shown). Children ,5 years old admitted with
pneumonia were more likely to present with wheezing (55/72,
76%) than persons $5 years old (29/64, 45%; P=0.0002), but
were less likely to present with tachypnea (persons ,5 years old:
28/71, 39%; persons $5 years old: 48/65, 74%; P,0.0001).
Headaches, muscle aches and shivering were significantly more
common among persons $5 years old admitted with pneumonia
compared to children ,5 years old (data not shown). There was
no significant difference by age in the proportion of hospitalized
pneumonia patients with cough, difficulty breathing, shortness of
breath, sputum production, sore throat, fever, rhinorrea, pleuritic
chest pain, oxygen saturation ,90% or diarrhea. Children ,5
Figure 3. Number of Patients with Respiratory Syncytial Virus by Month, Guatemala, 2008-2009. Panel A: Hospitalized pneumonia
patients. Panel B: Influenza-like illness patients.
doi:10.1371/journal.pone.0015826.g003
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respiratory virus (27/73, 37%) than were persons $5 years old
(5/65, 8%; P,0.001). There were no significant differences in
severe outcomes (admission to the ICU, mechanical ventilation or
death) between children ,5 years old and persons $5 years old
(data not shown).
Table 2. Characteristics of Pneumonia Patients by Influenza A Subtype– Guatemala, 2008-2009.
All influenza A**
No. (%)*
Influenza A subtype
No. (%)*
Characteristics N=138
Seasonal H1N1
N=38
pH1N1
N=76 P value
Age in years, median (IQR) 3.0 (0.7–38) 2.3 (0.7–25) 4.2 (0.7–37) 0.48
Sex, F 55 (40) 14 (37) 31 (41) 0.68
Previously sought care for this illness 71 (56) 20 (63) 45 (59) 0.75
Days from symptom onset to admission, median (IQR) 5 (3–8) 4 (3–8) 5 (4–8) 0.27
Took any medication before admission 88 (64) 26 (68) 53 (70) 0.89
Took antipyretics before admission 67 (50) 22 (58) 40 (55) 0.76
Took antivirals before admission 3 (2) 0 (0) 3 (4) 0.55
Clinical signs and symptoms at admission
Cough 129 (95) 33 (92) 75 (99) 0.06
Difficulty breathing 115 (85) 31 (86) 66 (87) 0.91
Shortness of breath{ 67 (82) 16 (80) 38 (83) 0.80
Sputum production 96 (71) 28 (78) 52 (68) 0.31
Sore throat{ 49 (65) 11 (65) 32 (73) 0.54
Fever{ 97 (70) 32 (84) 47 (62) 0.01
Rhinorrhea 85 (62) 23 (62) 50 (66) 0.71
Wheezing 84 (62) 25 (66) 44 (60) 0.51
Headache{ 51 (61) 14 (64) 29 (63) 0.70
Pleuritic chest pain{ 42 (59) 10 (53) 26 (65) 0.36
Tachypnea 76 (56) 27 (71) 42 (57) 0.14
Pulse ox ,90% 57 (51) 14 (58) 37 (53) 0.64
Myalgia{ 37 (47) 9 (41) 24 (52) 0.68
Chills 58 (43) 15 (40) 34 (45) 0.26
Diarrhea 25 (18) 10 (26) 13 (17) 0.25
Chest radiograph consistent with pneumonia 47 (64) 14 (56) 27 (71) 0.22
Underlying medical conditions
One or more conditions 26 (19) 8 (16) 14 (18) 0.93
Asthma 10 (8) 4 (9) 4 (5) 0.47
Lung disease 3 (2) 1 (2) 2 (3) 0.84
Diabetes 5 (4) 3 (7) 1 (1) 0.13
Chronic cardiovascular disease ˆ 7 (5) 2 (5) 5 (7) 0.37
Immunocompromised 1 (1) 0 (0) 0 (0) —
Pregnancy1 2 (29) 0 (0) 2 (17) 0.53
Current smoker 7 (13) 2 (20) 5 (16) 0.98
Coinfection with other respiratory virus 31 (22) 7 (18) 17 (22) 0.63
Respiratory syncytial virus 16 (12) 0 (0) 11 (15) 0.01
Adenovirus 14 (10) 5 (14) 7 (9) 0.49
Coinfection with Streptococcus pneumoniae¥ 11 (22) 2 (22) 6 (19) 1.0
Note: IQR = interquartile range.
*Percentages are a proportion of non-missing data.
**Includes 17 patients with influenza A that could not be subtyped, and seven patients with influenza A (H3N2).
{Only assessed in patients $2 years old.
{Measured temperature $38uC within first 24 hours of admission.
1Only evaluated in females $14 and ,45 years old.
ˆOnly evaluated in those $15 years old.
¥Only evaluated in those $10 years old.
doi:10.1371/journal.pone.0015826.t002
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children ,5 years old (12/56, 21%) were no more likely to have
sought care elsewhere prior to presentation at the ambulatory
clinic than persons $5 years old (33/139, 24%; P=0.73).
Children ,5 years old were more likely to present with cough
(65/65, 100%) than persons $5 years old (139/148, 94%;
p=0.04). Diarrhea was also more commonly reported from
children ,5 years old (10/65, 15.4%) than persons $5 years old
(8/148, 5%; p=0.02). Patients $5 years old were significantly
more likely to report muscle aches and shivering than patients ,5
years old (data not shown). There was no difference in the
proportion of children ,5 years old and persons $5 years old in
terms of viral coinfection (data not shown). Among ILI patients,
there were no significant differences in the presence of cough, sore
throat, rhinorrhea, sputum production, pleuritic chest pain,
difficult breathing or shortness of breath by age (data not shown).
Characteristics and clinical presentation of pneumonia
patients by influenza A subtype
About 40% of the influenza A cases were females, and there was
no significant difference in sex between pH1N1 and seasonal
H1N1 (P=0.68; Table 2). Treatment-seeking behavior and
treatment received prior to hospital admission for pneumonia
was similar between patients with seasonal H1N1 and pH1N1.
The interval between symptom onset and hospital admission was
similar for both subtypes, between four and five days.
Clinical presentation of hospitalized pneumonia patients with
influenza A was similar between patients infected with seasonal
H1N1 and pH1N1; cough, difficulty breathing and shortness of
breath were the most common symptoms reported by patients
with both subtypes (Table 2). However, a measured temperature
$38uC within the first 24 hours of admission was less frequent
among hospitalized pneumonia patients with pH1N1 (62%) than
among those with seasonal H1N1 (84%; P=0.01). We did not
evaluate the frequency of vomiting or nausea among these
patients, but there was no difference in the proportion of patients
reporting diarrhea by subtype (P=0.25).
As reported previously [22], in this population, the proportion
of hospitalized pneumonia patients with influenza A reporting a
chronic or underlying medical problem was very low, less than
20%, and there was no significant difference between patients with
seasonal H1N1 and pH1N1 (P=0.93). Asthma was the most
Figure 4. Age Distribution of Patients by Influenza A Subtype, Guatemala, 2008-2009. Panel A: Hospitalized pneumonia patients. Panel B:
Influenza-like illness patients.
doi:10.1371/journal.pone.0015826.g004
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years old hospitalized with seasonal H1N1; more than a quarter
(29%) of the female patients with pH1N1 in this age range was
pregnant, but this amounted to only two women.
Almost a quarter (22%) of hospitalized pneumonia patients with
influenza A were admitted to the ICU (Table 4). This proportion
was higher for patients infected with pH1N1 (28%) than for
seasonal H1N1 (18%) but the difference was not statistically
significant (P=0.28). We examined the proportion of hospitalized
pneumonia patients with influenza A admitted to the ICU before
the pandemic began in May 2009 (7/34, 21%) and after (23/104,
22%), but there was no statistical difference (P=0.85). The
proportion of patients with respiratory distress who required
mechanical ventilation was more than three times higher among
the hospitalized pneumonia patients with pH1N1 (11%) compared
with those with seasonal H1N1 (3%), but the difference was not
statistically significant (P=0.14).
The CFP was three times higher for hospitalized pneumonia
patients with pH1N1 (15%) compared to seasonal H1N1 (5%), but
this difference was not statistically significant (P=0.21) (Table 4).
The two deaths associated with seasonal H1N1 both occurred in
patients between 50 and 59 years of age during their hospitaliza-
tion. Out of the 11 deaths among patients with pH1N1, nine
occurred in the hospital and two within one day of discharge. Four
of the patients with pH1N1 who died were ,1 year old, two were
between one and 15 years old, two were between 20 and 49 years
old, and three were between 50 and 59 years old. There were no
deaths of patients with pH1N1 $60 years old.
Coinfection with another respiratory virus was similar between
hospitalized pneumonia patients with seasonal H1N1 and pH1N1
(P=0.52) (Table 2). However, there were different respiratory
viruses associated with coinfection by influenza A subtype:
adenovirus was the most common viral coinfection among the
hospitalized pneumonia patients with seasonal H1N1, with 13% of
the patients coinfected. In contrast, RSV wasthemostcommonviral
coinfection among hospitalized pneumonia patients with pH1N1,
coinfecting 14% of these patients. The significant difference in the
proportion of patients with pH1N1 compared with seasonal H1N1
coinfected with RSV was due to a muchgreater incidence of RSV in
2009 than in 2008, with the peak number of cases coinciding with
the 2009 influenza pandemic (Figure 3).
Among the 39 hospitalized pneumonia patients ,5 years old
with pH1N1, there was no difference in the proportion admitted
to the ICU between those patients coinfected with RSV (3/10,
30%) than those not coinfected with RSV (9/29, 31%; P=1.0). A
greater proportion (2/10, 20%) of the patients coinfected with
RSV than the patients not coinfected with RSV (2/29, 7%)
required mechanical ventilation, but the difference was not
statistically significant (P=0.27). Similarly, the CFP among
patients coinfected with RSV (3/10, 30%) was higher than that
Table 3. Characteristics of Patients with Influenza-Like Illness by Influenza A Subtype – Guatemala, 2008–2009.
All influenza A*
No. (%)**
Influenza A Subtype
No. (%)**
Characteristics N=246*
Seasonal H1N1
N=51
H3N2{
N=21
pH1N1{
N=162 P value
Age, median (IQR) 8 (4–15) 7 (3–14) 7 (3–22) 9 (5–15) 0.24
Sex, Female 116 (47) 26 (51) 12 (57) 72 (44) 0.45
Previously sought care for this illness 50 (23) 11 (32) 4 (31) 34 (21) 0.61
Days from symptom onset to presentation, median (IQR) 2 (1–3) 2 (1–3) 2 (1–2) 2 (1–3) 0.11
Clinical signs and symptoms at presentation
Fever{ 246 (100) 51 (100) 21 (100) 162 (100) 1.0
Cough 233 (95) 49 (96) 18 (86) 155 (96) 0.13
Headache, 193 (87) 44 (92) 14 (88) 125 (86) 0.82
Sore throat, 191 (86) 45 (92) 15 (94) 121 (84) 0.22
Myalgia, 169 (77) 39 (81) 13 (81) 109 (75) 0.65
Chills 181 (74) 39 (77) 15 (71) 117 (75) 0.94
Rhinorrhea 168 (69) 39 (78) 13 (62) 111 (69) 0.31
Sputum production 121 (50) 30 (60) 13 (62) 75 (47) 0.14
Pleuritic chest pain, 97 (45) 30 (64) 10 (67) 53 (37) 0.001
Difficulty breathing 101 (41) 30 (59) 12 (57) 55 (34) 0.002
Shortness of breath, 53 (24) 11 (23) 4 (25) 35 (25) 0.97
Diarrhea 21 (9) 7 (14) 1 (5) 11 (7) 0.24
Coinfection with respiratory virus 29 (12) 7 (14) 3 (14) 15 (9) 0.57
Respiratory syncytial virus 18 (7) 0 (0) 2 (10) 12 (7) 0.12
Adenovirus 7 (3) 5 (10) 0 (0) 2 (1) 0.005
Note: IQR = interquartile range.
*The total number of patients with influenza A includes one mixed pH1N1 and H3N2 infection, and 11 influenza A samples that could not be subtyped.
**Unless indicated otherwise, percentages are a proportion of non-missing data.
{Does not include one patient with a mixed pH1N1 and H3N2 infection.
{Measured temperature .38uC.
,Only assessed in patients $2 years old.
doi:10.1371/journal.pone.0015826.t003
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was not statistically significant (P=0.1). Of the four deaths
associated with pH1N1 among this age group, three (75%)
patients were coinfected with RSV.
There was no difference in the proportion of children and adults
$10 years old who were coinfected with S. pneumoniae by subtype
(Table 2).
Clinical presentation and characteristics of patients with
ILI
Less than a quarter (23%) of the ILI patients with influenza A
sought care outside the home before presenting at the health
center or health post, and this percentage did not differ
significantly by influenza A subtype (P=0.61) (Table 3). The
median number of days from onset of symptoms to presentation at
an ambulatory clinic for patients with influenza A was two days
and was similar across all influenza subtypes (P=0.11).
Clinical signs and symptoms of patients with ILI were similar
across influenza A subtypes (Table 3), apart from difficulty
breathing and pleuritic chest pain, which were significantly less
likely to be reported by ILI patients with pH1N1 than those with
seasonal H1N1 or influenza A (H3N2). We found a higher
proportion of patients with diarrhea among those with seasonal
H1N1 (14%) than either pH1N1 (7%) or H3N2 (5%), although
this difference was not statistically significant (P=0.24).
The proportion of ILI patients with influenza A who were
coinfected with another respiratory virus was higher among ILI
patients with seasonal H1N1 (14%) and H3N2 (14%) than pH1N1
(9%), but the difference was not statistically significant (P=0.57).
Whereas the proportion of ILI patients with pH1N1 who were
coinfected with RSV (7%) was higher than the proportion of
seasonal H1N1 (0%), the proportion of ILI patients with H3N2
coinfected with RSV was similar (10%), and there was no overall
difference by influenza A subtype (P=0.12).
Discussion
Although the 2009 influenza pandemic caused significant
concern in Guatemala and helped to increase recognition of
influenza as an important public health issue, the data we have
presented here suggest that in Guatemala, the clinical presentation
of pH1N1 was similar to that of the seasonal influenza viruses that
were circulating before and during the pandemic.
Despite reports of significant differences in the age distributions
of seasonal influenza A and pH1N1 in both temperate [8,26–27]
and tropical climates [16,18], we found similar age distributions
for both ILI and pneumonia associated with seasonal influenza A
and pH1N1. Both seasonal H1N1 and pH1N1 caused pneumonia
primarily in children ,1 year old; infants account for approx-
imately 3% of the Guatemalan population, but they made up 37%
and 39% of the hospitalized pneumonia patients with pH1N1 and
seasonal H1N1, respectively. Among ILI patients, school-age
children 5 to 14 years old accounted for a third to half of influenza
A cases, and they were the predominant age group affected by all
three influenza A virus subtypes.
Although not statistically significant, all indicators of severity
(i.e., admission to an ICU, mechanical ventilation and CFP) were
higher among hospitalized pneumonia patients with pH1N1 as
compared with seasonal H1N1. Because our study combined pre-
pandemic and pandemic periods, we analyzed whether changes in
practices or procedures could have resulted in findings of greater
severity for pH1N1 than seasonal influenza. The proportion of
hospitalized pneumonia patients admitted to the ICU was similar
before and after the pandemic began, and although use of
antivirals was rare, treatment with antivirals only occurred during
the pandemic period. There was no difference between hospital-
ized pneumonia or ILI patients in time to presentation at a health
facility by influenza A subtype.
There have been three other concurrent comparisons of
seasonal influenza and pH1N1 in hospitalized patients that
reported on severe outcomes; none found any significant
differences in the ICU admission rates or CFP by influenza
subtype, but all occurred in well-resourced settings where
antivirals would have been available for treatment [13–15]. We
report a higher CFP for pH1N1 than has been reported elsewhere,
but this is likely due, in part, to a limited supply of antivirals
available for treatment, and does not explain the higher CFP for
pH1N1 than seasonal H1N1.
One possible explanation for the higher CFP from pH1N1 in
Guatemala is the increase in RSV transmission during the
pandemic period. Viral coinfection, especially with RSV, has
been hypothesized to reduce the T helper cell 1 response, thereby
increasing disease severity [28]. Among the children ,5 years old
with pH1N1 who died, 75% were coinfected with RSV. It is not
clear whether RSV acted synergistically with pH1N1 to cause
more severe disease in these patients, or whether RSV itself might
Table 4. Outcomes of Pneumonia Patients by Influenza A Subtype– Guatemala, 2008–2009.
All influenza A*
No. (%)**
Influenza A subtype
No. (%)**
Outcome N=138
Seasonal H1N1
N=38
pH1N1
N=76 P value
Admitted to the ICU 30 (22) 7 (18) 21 (28) 0.28
Mechanical ventilation 9 (7) 1 (3) 8 (11) 0.14
Death{ 13 (9) 2 (5) 11 (15) 0.14
Length of hospital stay, days, median (IQR) 5 (3–7) 5 (4–7) 5 (2–9) 0.41
Symptom onset to death, days, median (IQR) 9 (7–16) 15.5 (15–16) 9 (6–16) 0.23
Age in years at death, median (IQR) 26 (0.9–54) 56 (55–57) 15 (0.9–50) 0.07
Note: ICU = intensive care unit; IQR = interquartile range.
*Includes 17 patients with influenza A that could not be subtyped, and seven patients with influenza A (H3N2).
**Percentages are a proportion of non-missing data.
{Includes two hospitalized pneumonia patients who died one day after being discharged from the hospital.
doi:10.1371/journal.pone.0015826.t004
Seasonal and Pandemic Influenza in Guatemala
PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e15826have been the cause of their death. Further investigation in this
population of the effect of RSV and influenza coinfection is
warranted.
Clinical symptoms of hospitalized pneumonia patients were
similar between seasonal H1N1 and pH1N1, except for measured
temperature $38uC in the first 24 hours after hospital admission,
which was significantly less frequent among patients with pH1N1.
We looked for differences in treatment seeking behaviors and
treatments taken before admission that could explain this finding,
but the use of any medication, and antipyretics in particular, did
not differ between hospitalized pneumonia patients with seasonal
H1N1 and pH1N1. A difference in fever has not been noted in
any other concurrent comparison of patients with seasonal
influenza A and pH1N1 [13–15].
Although there have been many reports of a higher proportion
of pH1N1 ILI patients with gastrointestinal symptoms [8–10,16],
we found no difference in the proportions of hospitalized
pneumonia or ILI patients with diarrhea by subtype. It is possible
that our use of a stringent case definition for diarrhea may have
missed an association with more mild gastrointestinal symptoms
such as nausea.
A recent comparison of seasonal influenza and pH1N1 cases in
Philadelphia found more lower respiratory tract symptoms (i.e.,
cough and pleuritic chest pain) among pH1N1 than seasonal
influenza cases [14]; we did not find any significant differences in
the prevalence of these symptoms among hospitalized pneumonia
patients, but among ILI patients, both difficulty breathing and
pleuritic chest pain were significantly more common among
seasonal influenza patients, rather than those with pH1N1. It is
possible that during the pandemic, patients with lower respiratory
tract symptoms were more likely to proceed directly to the hospital
for treatment.
This study has several important strengths. Case definitions,
laboratory diagnostics and procedures for data collection did not
change during the time period covered in this report; this
eliminates the possibility that findings were related to changes in
surveillance methodology as a result of the pandemic, which can
be a problem when using historical controls. A broad case
definition permitted inclusion of influenza cases that might
otherwise go undetected; for example, requirement of fever in
the case definition for severe acute respiratory disease could miss a
significant proportion of serious illness associated with both
seasonal H1N1 and pH1N1.
The main limitation of this study is the relatively small number
of cases of influenza that could be analyzed, which limits the
power to detect differences in characteristics and clinical
presentation. Because the sample size was small, it is possible that
we were not able to identify important differences between
seasonal influenza A viruses and pH1N1 influenza that might
appear in a larger data set, especially related to signs of severity
which were consistently elevated with pH1N1 but were not
statistically significant. This limitation has been noted for least one
other similar study [29], and should be taken into consideration
when evaluating results from our study. Because surveillance for
pneumonia in Quetzaltenango was initiated only four months
before the pandemic began, and surveillance for ILI was initiated
two months after the first case of pandemic influenza, the majority
of the seasonal influenza cases come from Santa Rosa and this
may have introduced some unmeasured biases in the comparison
between seasonal influenza and pH1N1. Although we did not find
a difference in the number of days between symptom onset and
care seeking at our surveillance clinics and hospitals between
seasonal influenza A viruses and pH1N1, we are unable to
determine from this dataset whether there was an increase in the
probability of healthcare seeking as a result of the pandemic. We
used a standard definition for ILI that includes a measured fever
and this is likely to have caused us to miss cases of influenza that
presented without fever.
In conclusion, the epidemiology of pH1N1 in Guatemala was
not significantly different from that associated with the seasonal
influenza subtypes circulating locally before and during the
pandemic in terms of the age groups most affected and clinical
signs and symptoms. In Guatemala, influenza is largely a disease of
children, with the most severe disease in infants, and targeted use
of influenza vaccine in children may be warranted. The 2009
influenza pandemic raised awareness of the burden of disease
caused by influenza in the tropics; increased attention should be
extended to monitoring and addressing the morbidity and
mortality associated with seasonal influenza.
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